Dose-Dependent Pharmacokinetics of Amphotericin B Lipid Complex in Rabbits

Amphotericin B lipid complex (ABLC) was recently approved by the Food and Drug Administration for treatment of patients with invasive fungal infections who are intolerant of or refractory to conventional amphotericin B therapy. Little is known, however, about the pharmacokinetics of this new antifun...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Walsh, Thomas J., Jackson, Andre J., Lee, James W., Amantea, Michael, Sein, Tin, Bacher, John, Zech, Loren
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 2000
Schlagworte:	Pharmacology
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90015/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10898677/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.8.2068-2076.2000
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!